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Abstract 
 
This report was commissioned by the NHS National Programme Director for End of Life Care in 2008 to 
inform the development of national policy regarding end of life care prior to the controversy surrounding 
misuse of the Liverpool Care Pathway (Ellershaw and Wilkinson, 2003) and its subsequent discontinuation 
from use in clinical practice. It was situated on the Department of Health’s webpages for end of life care 
until taken down following internal reorganisation of the website and the redistribution of responsibility for 
end of life care within the National Health Service some years later. The subject of end of life 
prognostication was as sensitive then as it is now, although in many respects, it is much more visible as a 
subject for social, political and academic debate these days, not least because of the many examples 
contained within subsequent reviews of the Liverpool Care Pathway’s misuse by clinicians or practitioners 
who failed in some instances to fully understand the importance of ‘diagnosing dying’ before putting 
individuals onto the care pathway, and their failure to heed the very first rule of its use, namely; that such 
decisions should always be discussed with those who were dying and their close family members before 
putting them on the pathway wherever possible.  
 
It is my view that the majority of clinical interventions contained within the Liverpool Care Pathway for the 
Dying were, and continue to be clinically sound when used appropriately; although the evidence base for 
some of them remains sparse, and it is an area of practice which continues to be massively under-resourced 
and under-researched even to this day. Rather, the problem in many publicised cases outlined in the wake 
of the Liverpool Care Pathway controversy lay in the inability of clinicians to prognosticate accurately which, 
when combined with a natural aversion to having difficult conversations with patients and family members, 
and the lack of investment or interest in palliative and end of life education led to inevitable mistakes 
occurring. I still recall the evident glee of one manager who called me to explain why she was withdrawing 
staff members from an end of life programme I was running because the ‘LCP’ was being introduced into 
her ward and that was all that was needed to provide good end of life care while reducing her training 
budget. We clearly know better now, but the clinical science of prognostication, or ‘diagnosing dying’ which 
I much prefer, is notoriously imprecise, not least because people die from myriad causes, each of which 
have their own unique dying trajectories although other biopsychosocial factors also play their part in the 
way and speed with which any given individual will deteriorate at the end of life.  
 
The review undertaken was neither funded nor intended to be a comprehensive systematic review of the 
literature, but rather a twenty-page summary and starting point for discussion about the way in which we 
recognise that someone is dying and how we could or should respond to that fact. The need for discussion is 
as pertinent today as it was then, not least because of the fact that more patients and family members 
expect us to have answers to these questions, though clearly this is still a work in progress for many of us 
and will continue to be until we fully understand the benefits of having such conversations with them.  
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1.0 Introduction 
 
It has been estimated that approximately 280 people per 100,000 die from cancer each year in the 
UK of whom 25–65% will require help from a palliative care support team and 15–25% will receive 
inpatient hospice care. Over twice this proportion (690 per 100,000) will die from non-malignant 
causes in the same time, and whilst a small proportion of these will die suddenly without warning, 
the majority will have predictable signs that their underlying circulatory, respiratory or 
neurological conditions are worsening (Murtagh et al., 2004). Whilst little may be done to reverse 
these conditions by this stage, there is considerable evidence that the symptoms associated with 
end-stage disease may be successfully alleviated after a thorough end-of-life care assessment and 
the provision of appropriate palliative or end-of-life interventions aimed at both these and the 
support needs of patients and their carers. There is little agreement however, as to what 
constitutes end-of-life care or the optimum time at which such an assessment should take place. 
This review of the literature was therefore commissioned by the National Programme Director for 
the NHS End-of-life Care Programme to provide a summary of the ways in which end-of-life care is 
currently defined, and to identify the factors currently used to trigger an end-of-life assessment.   
 
2.0 Methodology 
 
A series of searches using MEDLINE, CINAHL, CancerLit, PsychInfo and the Applied Social Science 
Index (ASSIA) from 1995 to 2008 was conducted using the search terms: end-of-life, palliative, 
terminal, hospice, death and dying connected by the Boolean operator ‘or’. These search terms 
were combined using the Boolean operator ‘and’ with the following secondary search terms: 
defin*, prognos*, diagnos*, predict*, identify*, indicat* again connected by the Boolean operator 
‘or’. These terms were used to identify papers using the terms: definitions, defining, prognosis, 
prognostication, diagnosing, diagnosis, predict, predicting, identify, identifying and indicators in 
relation to the first set of search terms in the title or abstract of the literature.  
 
The search was undertaken between August and November 2008 and was limited to English 
language papers. An initial screening process looking at the papers’ titles was then conducted. The 
vast majority of papers were rejected and no single paper claimed to have investigated existing 
definitions of end-of-life care as its sole focus. As a result of this, the abstracts of 568 papers were 
then sampled. Sixty-two papers were then chosen on a theoretical sampling basis as it was often 
impossible to determine whether the papers contained a definition of end-of-life care or not. 
Most did not, and many others alluded to the same few definitions, most notably those 
originating in the work of Lynn and colleagues (Lorenz et al., 2008; Lorenz et al., 2006; Lynn and 
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Goldstein, 2003; Lynn et al., 2002; Lunney et al., 2002; Lynn, 2000; Hoffman et al., 1997; Lynn et 
al., 1997). Twenty-nine papers looking at prognostication were selected with regard to the second 
objective of the review and a supplementary search of articles in press was also conducted on 
Elsevier’s ScienceDirect and Wiley-Blackwell’s WileyInterscience search engines to identify any 
papers currently in print using the same criteria. Review of the selected papers’ reference lists 
revealed another 19 papers, and a search of the gray literature, including personal communication 
with the author of one set of papers identified a further four papers including the draft copy of an 
article not yet submitted for peer review.     
 
3.0 Findings 
 
3.1 Distinguishing end-of-life care from palliative and supportive care 
 
Interest in end-of-life care as a separate and distinctive entity from palliative or terminal care has 
its origins in North America and in particular, the work of Joanne Lynn and her colleagues (Lorenz 
et al., 2008; Lorenz et al., 2006; Lynn and Goldstein, 2003; Lynn et al., 2002; Lunney et al., 2002; 
Lynn, 2000; Hoffman et al., 1997; Lynn et al., 1997). It is becoming increasingly influential in 
determining health policy for those with life-limiting illness (NHS Confederation, 2005), and for 
those whose life is coming towards its natural conclusion, particularly in the elderly (National 
Institute for Clinical Excellence, 2004; Department of Health 2003). However, the term itself is 
somewhat ambiguous, and has been variously used to describe the care given to patients in the 
last year, months, weeks, days, or even hours of life depending upon the nature of the care 
setting or the stance of individual researchers themselves (Payne et al., 2002). Froggatt and Payne 
(2006) point to the disparate nature of two common tools used within the UK to enhance the care 
of dying patients by way of an exemplar in this respect, the first being the Liverpool Care Pathway 
for the Dying (Ellershaw and Wilkinson, 2003) which outlines the care to be provided to dying 
patients in the last few hours or days of life in a variety of in-patient care settings, and the Gold 
Standards Framework which provides the basis for optimum care delivery in the community 
during the final weeks or months of life. Indeed, the authors of the Gold Standards Framework go 
further, suggesting that it is ‘concerned with helping people to live well until the end-of-life and 
includes care in the final year of life for people with any end stage illness.’ (Gold Standards 
Framework accessed 24th October, 2008 http://www.goldstandardsframework.nhs.uk).  
 
This ambiguity is not helped by recent policy documents on the subject, one end-of-life care 
strategy (National Council for Palliative Care, 2006) arguing that, ‘it may be useful to regard ‘end-
of-life care’ as simply an everyday expression that may be easily understood by the general public 
and in that context does not require formal definition’ (p2). In line with this there is little evidence 
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in the literature reviewed that any large-scale prospective studies have been carried out to 
ascertain whether the meaning of the term is ‘easily understood’ by the general public as the 
document suggests, or the degree to which lay conceptualisations of the term accord with those 
of health professionals. Such research would indeed be difficult to undertake given that there is so 
little agreement about the meaning of the term amongst professional carers, although to its 
credit, the report does go on to assert that, ‘this does not lessen the need to produce a common 
understanding of its meaning for health and social care professionals’ (p2).  
 
Notwithstanding this, the document studiously avoids any attempt to do so in detail, arguing 
instead that its onset depends upon a variety of factors including the nature of the patient’s final 
illness (its onset varying between those with cancer, organ failure, dementia and age-related 
frailty for instance), the personal or emic perspective of individual patients; and differences in the 
clinical or prognostic opinions of individual professionals which may vary enormously depending 
upon their clinical experience or philosophical stance. Haematologists for example, may have very 
different conceptions of when end-of-life care is appropriate than someone working in palliative 
care, oncology or other settings, and there is evidence that the views of haematology nurses may 
vary markedly from those of their medical colleagues in this respect, indicating that 
interprofessional as well as lay/professional differences of opinion on the topic may exist 
(Zimmermann, 2007; McGrath and Holewa, 2007; McGrath and Holewa, 2006; Boyce et al., 2003). 
The report’s authors point out that clinical indicators too have been suggested, including weight 
loss, frailty, poor appetite, breathlessness, poor performance status, dependence upon others for 
assistance with activities of daily living and pain (Porock and Oliver, 2007; Porock et al., 2005; 
Della Santina and Bernstein, 2004; Elkington et al., 2004; Jacobs et al., 2002; Wilson, 2002; 
Nikoletti et al., 2000; Morris et al., 1990). Lorenz et al. (2008), Knause et al. (1995) and Fox et al. 
(1999) demonstrate the paucity of physician’s prognostic abilities however, many doctors 
estimating during the patient’s last week of life that they may live for a further two or even six 
months.  
 
As a consequence of this, the best definition that the National Council for Palliative Care proffers 
in their report is that, ‘end-of life care is simply acknowledged to be the provision of supportive 
and palliative care in response to the assessed needs of patient and family during the last phase of 
life’ (p3); although again, neither the ‘last phase of life’ nor the time at which this commences is 
defined with any certainty. The authors do argue however, that ‘in most cases, end-of-life care 
does not begin earlier than one year before death’ (p3), although no evidence is provided to 
support this claim and it is difficult to determine why they arrive at such a conclusion if they 
genuinely believe that end-of-life care is primarily the ‘provision of supportive and palliative care 
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in response to the assessed needs of patient and family’, given that these needs may (and often 
do) arise before this arbitrary cut-off date. Indeed, if one looks at supportive care for example, the 
National Institute for Clinical Excellence (NICE) (2004) supports the view of the National Council 
for Hospices and Specialist Palliative Care Services (NCHSPCS) that supportive care for people with 
cancer is ‘the comprehensive care of patients and their families from the time of diagnosis, or even 
pre-diagnosis, throughout both curative and palliative treatments’ (Ahmedzai et al., 2004 p2199). 
The NCHSPCS state on their own website that supportive care ‘helps the patient to maximise the 
benefits of treatment and to live as well as possible with the effects of the disease’, and ‘should be 
given equal priority alongside diagnosis and treatment’. NICE (2004) argue therefore, that 
contrary to much of the published literature, supportive care ‘is not a response to a particular 
stage of disease, but is based on an assumption that people have needs for supportive care from 
the time that the possibility of cancer is first raised’ (p18).  
 
Supportive care is very different from palliative care therefore, which is the ‘person-centred 
attention to symptoms, psychological, social and existential distress in patients with limited 
prognosis, in order to optimise the quality of life of patients and their families or close friends’  
(Ahmedzai et al., 2004 p2192). Moreover, NICE make clear that they consider end-of-life care is, in 
many instances, a sub-speciality of specialist palliative care (itself a sub-speciality of supportive 
care) when stating that ‘although palliative care encompasses many of the elements identified as 
‘supportive care’, there are well-defined areas of expertise within specialist palliative care to which 
patients and carers may need access, such as interventions to respond to unresolved symptoms 
and complex psychosocial issues for patients with advanced disease, complex end-of-life issues 
[and] bereavement issues’ (NICE, 2004 p21 emphases mine). It is also clearly apparent that NICE 
regard end-of-life care as the care provided to cancer patients in the very final stage of their 
disease as, for example, in their exhortation that ‘Commissioners should ensure that continuous 
support can be provided for patients in their homes as end-of-life approaches, in compliance with 
the wishes of patients and carers’ (p114).  
 
It should be noted however, that the NICE guidelines are concerned solely with the provision of 
supportive, palliative (and by definition, end-of-life) care to patients with malignant disease, in 
which it may be easier to define a stage at which end-of-life care should begin, the obvious failure 
of treatment to keep the disease in check, tumour growth, recurrence or widespread metastases 
making this more obvious than the gradual and more subtle deterioration likely to take place in 
end-stage cardiac or pulmonary disease, progressive neurological disorders such as amytrophic 
lateral sclerosis and motor neurone disease; or the insidious onset of Alzheimer’s or Parkinson’s 
disease with advancing age. Writing from a gerontology perspective, Froggatt and Payne (2006) 
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argue that the initiation of end-of-life care is contingent upon knowing that someone is dying, a 
process which ‘can vary from a very short time period of hours or days before an individual dies to 
the last few years of a person’s life’, a period they argue which is ‘more easily defined 
retrospectively than prospectively’ (p346).      
 
3.2 Definitions of end-of-life care 
 
The US National Institutes of Health (2004) argue that there is no exact definition of the end-of-
life, and consequently, no formal definition of end-of-life care. They suggest that both terms are 
used appropriately where chronic disease is present, although the symptoms of this may be 
permanent or temporary in nature. They specify however, that the underlying disease process 
should be irreversible, and that the symptoms or impairments resulting from it require either 
professional, or informal family or volunteer care in the time leading up to death. The guidelines 
point out that advancing age, frailty and comorbidity may be surrogates for a life-threatening 
illness, but argue that end-of-life care should not be defined by a specific timeframe unless 
reliable prognostic evidence is available to support such a decision (as might be the case with 
some cancer deaths). The World Health Organisation (1998) define end-of-life care as ‘the active, 
total care of patients whose disease is not responsive to curative treatment’, and argue that the 
aim of care in such cases is, ‘to attain maximal quality of life through control of the myriad 
physical, psychological, social, and spiritual distress of the patient and family’. This definition is 
supported in respect of lung cancer patients by Griffin et al (2003), and it is appropriate perhaps, 
that a  definition which addresses each of the biopsychosocial domains affected by this complex 
illness should be preferred by this group of researchers.  
 
Writing about end-of-life care in cancer patients, Hewitt and Simone (1999) argue that end-of-life 
care ‘extends beyond physical symptoms to include supportive, psychological, spiritual and 
emotional care’ (p25), and suggest that this occurs ‘when the goals of care shift to the quality of 
life and symptom relief’ (p25). Citing Lynn et al’s (1997) seminal work, they point out that it 
includes ‘the management of physical or emotional symptoms and limitation on functions, the 
provision of pain relief and palliation to improve or maintain quality of remaining life, counseling 
on the potential harm or benefit of aggressive life extending treatments, respite, social support 
and other services to relieve caregiver burden, advance care planning and bereavement support’ 
(p26). The relationship between end-of-life care and counselling against ‘aggressive futile 
measures’ (especially amongst US long term care residents) has been commented upon by a 
number of writers, most notably Kane (2003) in a WHO publication on health in the elderly who 
suggests that ‘end-of-life care is closely related to rationing in that it offers a way to limit 
expensive, perhaps futile care in an ethical context driven by consumer empowerment’, although 
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he notes that, ‘to the surprise of many investigators, many older people are not anxious to cede 
access to potentially life saving technology, even if the likelihood of benefits is slim’ (p77). It is 
essential therefore, that end-of-life care does not become associated with any policy agenda 
aimed at restricting patients’ life (or death) choices in such a way if it is to be accepted by the 
general public as a bona fide attempt to improve (rather than restrict) care at the end-of-life.  
 
Another oncology perspective on end-of-life care is provided by the European Society of Medical 
Oncology who define it as, ‘palliative care when death is imminent’. These authors argue that it is 
provided to ‘patients who are imminently dying and their families who have very special and often 
intense needs which commonly require individualized and intensive clinical care’ at such a time 
(Cherny et al., 2003). Here the relationship with palliative care is once again reiterated, although 
end-of-life care is conceptualised as a specific intervention offered in the period immediately 
preceding death. This contrasts sharply with a definition contained in the Oxford Handbook of 
Palliative Care however, which states that end-of-life care ‘usually refers to the care of a person 
during the last part of their life’, which they regard as commencing at the point at which, ‘it has 
become clear that the person is in a progressive state of decline’. Unlike Cherny et al. however, the 
authors of this definition argue that, ‘end-of-life care is usually a longer period than the time 
during which someone is considered to be dying’, and point out that in the UK, the term is almost 
exclusively used by health care professionals in contrast to patients and their families who still 
tend to refer to ‘terminal illness’ or ‘terminal care’ when discussing end-of-life issues. The 
preference for the new terminology may owe more to professional concerns than patient 
sensitivity therefore, the moreso as it is clear that patients and their families are increasingly 
confused by the multiplicity of terms and definitions now used to describe what they consider to 
be the same thing. 
 
A cardiac perspective on end-of-life care is provided by Zambrowski et al. (2005), who suggest that 
end-of-life care is ‘delivered in order to provide symptom relief, comfort and support to patients 
and their families as they cope with managing an illness when optimal treatments have failed to 
halt progression of the illness or relieve symptoms’ (p569). Like Cherny et al (2003), they use the 
notion of imminence to determine when end-of-life care should start, arguing that it is 
appropriate when ‘the likelihood is thought to be high that death is imminent within the coming 
weeks to months’ (p569), and consider palliative care services as part of this provision. The 
emphasis upon physical symptoms is in stark contrast to that provided by the US Department of 
Elder Affairs however, who take a more holistic approach, defining it as ‘care provided to meet the 
physical, psychological, social, spiritual, and practical needs of terminally ill patients and their 
caregivers’. This conceptualisation is more similar to the Gold Standards Framework in the UK 
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which also takes a more holistic view of its purpose when saying that, ‘end-of-life care is 
concerned with helping people to live well until the end-of-life and includes care in the final year of 
life for people with any end stage illness’, but is at odds with a definition contained in Ferrell and 
Coyle (2001) that end-of-life care refers ‘explicitly to the final weeks of life when death is 
imminent’ (p28).  
 
In recent years, the scope for further confusion has been raised in the UK by a desire to separate 
‘generic’ end-of-life care (i.e. that provide by generalists in the primary care sector) from that 
provided by specialist palliative care services. Shipman et al. (2008) report the result of a national 
consultation exercise in the UK which elicited the views of 210 health care professionals, 
commissioners, academics, and representatives of user and voluntary groups on end-of-life care 
and ‘generic end-of-life care’ using a modified nominal group technique. The response rate to 
invitations was 74% of those invited (210/285). Short semi-structured questionnaires standardised 
for use across five locations were used, and these were followed up by interviews with selected 
respondents. Questions included views about the generalist’s role, specific local concerns, access, 
education, training, and support. The consultation’s facilitators defined generalist end-of-life care 
as ‘care provided by health or social care professionals other than those whose remit was specialist 
palliative care, and proposed that end-of-life care consisted of care provided within the last year(s) 
of life to anyone with an advanced progressive disease that was likely to shorten their life’. There 
was little consensus amongst respondents however, about what end-of-life care or indeed, 
generalist end-of-life care meant, each having different meanings for some respondents and none 
at all for others. There was considerable variation in respondents’ definitions of generic palliative 
care and some dispute about when this ought to commence. Some respondents argued that it 
might include the last year or more of a patient’s life whilst others considered that it only 
concerned the last few days of a patient’s life. One respondent thought that it might incorporate 
the last two years of a patient’s life.  As a consequence, the researchers’ definitions of end-of-life 
care were not fully accepted, and the personal views of respondents varied enormously in terms 
of what generic end-of-life care meant, when it should begin, and how long a period might be 
involved.   
 
Writing from an ethical perspective, Brook-Hamilton (2000) argues that end-of-life care can be 
defined as ‘medical and other supportive care given to a person during the final six months of life’, 
but he also notes that ’end-of-life care is also defined by the expectations of the patients and 
family as to the final period of the patient’s life, thus the boundaries of what constitutes end-of-life 
care are not definite’ (p73). This blurring of the boundaries is even more likely if one accepts the 
US Institute of Medicine’s assertion that quality experience at the end-of-life is ‘one that is free 
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from avoidable distress and suffering for patients, families and caregivers; in general accord with 
patients and families’ wishes; and reasonably consistent with clinical, cultural and ethical 
standards’ (p516). Papers emanating from the UK say little about social or cultural determinants 
of its meaning, although a number of studies assessing the importance of culture, ethnicity and 
social factors have been undertaken in the United States (Carr and Khodyakov, 2007; Brody and 
Hunt, 2005; Gabbay et al., 2005), and a broader discussion of such issues can also be found in 
Kellehear (2008) and Kemp (2005). Table 1 overleaf provides a summary of the main definitions 
discussed above. These show the similarities and differences between different 
conceptualisations of the subject within the literature - especially in respect of when end-of-life 
care should begin. Criticisms that the topic is poorly and inconsistently defined appear to be true 
from the results of this review, but it is also apparent that one definition is unlikely to satisfy the 
multivariate needs of so disparate a community of practice or adequately explain the complex and 
highly individual care needs of different patients.  
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Table 1: Summary of main end of life definitions 
Source Definition 
Oxford Handbook of Palliative 
Care 
‘the care of a person during the last part of their life [when] it has become clear 
that the person is in a progressive state of decline.’ 
US Department of Elder Affairs ‘care provided to meet the physical, psychological, social, spiritual, and practical 
needs of terminally ill patients and their caregivers’ 
World Health Organisation (1998) ‘the active, total care of patients whose disease is not responsive to curative 
treatment [intended] to attain maximal quality of life through control of the 
myriad physical, psychological, social, and spiritual distress of the patient and 
family.’ 
UK Gold Standards Framework ‘end-of-life care is concerned with helping people to live well until the end-of-life 
and includes care in the final year of life for people with any end stage illness.’ 
An oncology perspective  
(European Society of Medical 
Oncology - Cherny et al, 2003) 
‘delivered in order to provide symptom relief, comfort and support to patients 
and their families as they cope with managing an illness when optimal 
treatments have failed to halt progression of the illness or relieve symptoms 
[appropriate for] patients who are imminently dying and their families who have 
very special and often intense needs which commonly require individualized and 
intensive clinical care.’ 
A cardiac perspective  
(Zambrowski et al., 2005) 
‘care delivered in order to provide symptom relief, comfort and support to 
patients and their families as they cope with managing an illness when optimal 
treatments have failed to halt progression of the illness or relieve symptoms 
[when] ‘the likelihood is thought to be high that death is imminent within the 
coming weeks to months.’ 
A long-term care perspective 
(Lynn et al., 1997) 
‘the management of physical or emotional symptoms and limitation on functions, 
the provision of pain relief and palliation to improve or maintain quality of 
remaining life, counseling on the potential harm or benefit of aggressive life 
extending treatments, respite, social support and other services to relieve 
caregiver burden, advance care planning and bereavement support.’ 
A ‘generic’ end-of-life care 
perspective 
(Shipman et al., 2008) 
‘care provided by health or social care professionals other than those whose 
remit was specialist palliative care, and proposed that end-of-life care consisted 
of care provided within the last year(s) of life to anyone with an advanced 
progressive disease that was likely to shorten their life.’ 
An ethical perspective  
(Brook-Hamilton, 2000) 
‘medical and other supportive care given to a person during the final six months 
of life [which] is also defined by the expectations of the patients and family as to 
the final period of the patients life.’ 
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3.3 Further definitions from the literature  
 
Many papers studied during the course of this review failed to define what they meant by end-of-
life care even as they bemoaned the absence of a clear definition. One early paper by Asch et al. 
(1997) which elicited the views of 468 critical care nurses in US hospitals found that the subject 
was a ‘gray area’ to 32% of the respondents questioned, although the paper itself offers no help 
by way of a definition of the term; and few others make any real attempt to define this important 
concept or variable in their papers. Mularski et al (2007) point out however, that end-of-life care 
encompasses many possible courses of action in order to arrive at an agreed plan of care, and 
claim to have used a ‘broad definition’ of the term in their review of 99 end-of-life outcome 
measures, although this definition is not to be found in their paper, a problem inherent in any 
search for end-of-life care definitions within the literature. They point out however, that 
prognostication is poor and imprecise for most non-malignant conditions, and argue that different 
diseases show different patterns of functional decline as the patient moves towards the end-of-
life, indicating perhaps, their reluctance to define so elusive a concept in too precise a way. 
Steinhauser et al. (2000) argue meanwhile that whilst physicians focus upon the physical aspects 
of a patient’s deteriorating condition, patients and their families tend to imbue the end-of-life 
with broader psychosocial and spiritual meanings which are shaped by a lifetime of experience 
and interwoven with personal and symbolic as well as spiritual meaning.  
 
One paper by Nolan and Mock (2004) which considers the development of a new framework for 
end-of-life care uses instead, a definition contained within the US Institute of Medicine Report, 
Describing Death in America carried out by Lunney et al. (2003). This describes the end-of-life as 
‘the period of time during which an individual copes with declining health from an ultimately 
terminal illness, from a serious though perhaps chronic illness, or from the frailties associated with 
advanced old age – even if death is not clearly imminent’ (p22). This definition makes clear that 
end-of-life care needs to include the care of those with an identifiable terminal illness such as 
recurrent cancer, those illnesses regarded as chronic (though life threatening), such as pulmonary 
or cardiac disease, and those considered to be at an age (or approaching such an age) where 
death from as yet undiagnosed causes might reasonably be expected to occur. This is a very broad 
definition however, and the assumption that everyone covered in the list has similar end-of-life 
care needs is to be avoided wherever possible.    
 
When discussing the provision of palliative care for people with chronic obstructive pulmonary 
disease (COPD) for example, Murray et al. (2006) point out that there is a ‘stark contrast between 
the experiences and services available for people with advanced cancer and COPD’, arguing that ‘in 
the last year of life, patients with COPD have worse quality of life, greater limitation of activity, 
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and more anxiety and depression than patients with lung cancer’ (p363). Citing work by Gore et al. 
(2000), these authors draw attention to the fact that over 80% of patients with COPD are house-
bound whilst a third of them are also chair-bound. In spite of this however, less than half of them 
have the mobility aids that might reduce their social isolation; and very few recognised as being at 
the end-of-life are offered an opportunity to discuss their prognosis or make informed decisions 
about their end-of-life care as cancer patients are likely to be. COPD is a good example therefore, 
of an illness in which gradual organ failure is marked by frequent, potentially severe exacerbations 
of the illness or superimposed infections, any of which may prove fatal (Murray et al., 2005; Lynn 
and Adamson, 2003). In such circumstances, Murray and his colleagues argue that death may 
occur suddenly and unexpectedly, long before a terminal prognosis has been made by doctors 
who are more likely to overestimate their patient’s survival than underestimate it (Christakis and 
Lamont, 2000), and thus deny them the opportunity to discuss end-of-life issues with family 
members and those providing their medical and nursing care. 
 
Describing this situation as ‘prognostic paralysis’ (Murray et al., 2005), these authors provide 
some helpful questions to help professional carers broach such issues with their patients 
including: 
 
 What is the most important thing in your life right now? 
 What keeps you going? 
 You seem cheerful at present, but do you ever feel down? 
 If things got worse, where would you like to be cared for? 
 
To which I would also add, ‘if things got worse, how far would you like us to go in maintaining your 
life knowing that these are unlikely to be successful or have unforeseen consequences?’ They also 
advocate use of the ‘surprise’ question, i.e. ‘would it surprise me if this patient were to die within 
the next six months’, and point out that the uncertain disease trajectory in COPD may help to 
facilitate conversations of this sort given that these questions can be asked relatively early within 
the last likely year of life without necessarily alarming the patient or making them feel that death 
is imminent. Unlike many other authors, Murray et al. (2006) also outline some clinical risk factors 
which should alert those caring for such patients to the need for such a conversation including:  
 
 Hospital admission for severe exacerbation of COPD 
 Being house or chair bound due to COPD 
 Having a FEV1 of 30% or less 
 Requiring long-term oxygen therapy 
 A diagnosis of depression or poor quality of life 
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 Co-morbidities such as heart failure or diabetes 
 A low body mass index.  
 
One systematic literature review on the evidence base for improving palliative care outcomes at 
the end-of-life conducted by Lorenz et al. (2008) pointed out that there is inconsistent use of 
terminology when defining the end-of-life, and a variety of methods used to assess its onset, 
including clinician assessment that the patient is ‘actively’ dying, clinical characteristics, survival 
indices, and psychological preparedness or ‘patient readiness’ for death. These authors also point 
out that no precise definitions or performance characteristics of these terms have been published, 
and argue that clinicians may prefer to define the end-of-life as ‘having a fatal condition, risking 
death with the next exacerbation’ or when the patient is, ’beginning to acknowledge the 
seriousness of the situation’ (p149-150). They suggest however, that waiting for near certainty 
would fail to identify most dying people and argue that an end-of-life care assessment needs to be 
conducted much earlier for many people living with serious life-threatening illness, and advocate 
that clinicians ask themselves the so-called ‘surprise question’ i.e. ‘would it be a surprise if this 
patient were to die within the next six months’, a question which is being advocated widely, but 
also lacks rigorous testing although some anecdotal evidence for its utility exists. 
 
One prospective cohort study made use of this question together with the Charlson Comorbidity 
Index and Karnofsky Performance Status scores to assess the likelihood of death occurring within 
a six month period in 147 haemodialysis patients (Moss et al., 2008). The study found that the 
mortality rate for the group least expected to die within six months was 10.6% compared to 29.4% 
for those expected to die within this timeframe. Although the numbers of patients dying was quite 
small (22 patients or 15% of the sample), those thought likely to die were 3.5 times more likely to 
do so than those expected to live (odds ratio 3.507, 95% CI 1.356 to 9.067, P = 0.01), leading the 
authors to conclude that the ‘surprise’ question is an effective identifier of mortality risk for 
patients undergoing dialysis. In general, patients expected to die were older (72.5 ± 12.8 versus 
64.5 ± 14.9) and had a higher comorbidity score (7.1 ± 2.3 versus 5.8 ± 2.1) as well as a lower 
performance status score (69.7 ± 17.1 versus 81.6 ± 15.8), which indicates that clinician’s intuitive 
judgements when asked this question may have some basis in objective measures of patients’ 
age, comorbidity and functional status. However; another survey of 274 second year nephrology 
fellows of the American Medical Association found that 12% of respondents underestimated the 
annual mortality rate (20-29% per annum) of dialysis patients whilst 21% overestimated it; 
indicating that much needs to be done before those caring for renal patients feel competent to 
assess annual mortality risk in their patients (Holley et al., 2003), most respondents saying that 
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they felt significantly better prepared to manage haemodialysis than initiate discussions about 
end-of-life care or determine when this might be appropriate.  
 
This finding is supported by the Study to Understand Prognosis and Preferences for Outcomes and 
Risks of Treatments (Knaus et al., 1995), which suggested that many renal patients die prolonged 
and sometimes painful deaths after receiving unwanted interventions long after these have 
become futile, physicians all too often appearing ill-equipped or lacking sufficient confidence to 
prevent this from occurring (Garvin and Chapman, 1995), and unaware that patients’ priorities 
had changed by the time that treatment cessation became necessary (Steinhauser et al., 2000). 
The study by Steinhauser et al. asked patients (n=340), bereaved family members (n=332), 
physicians (n=361) and other care providers (n=429) to rate the importance of 44 quality of life 
attributes using a 5-point Likert scale. They also asked respondents to rank in order of importance 
9 attributes derived from earlier focus group work. The study demonstrated that patients’ 
psychosocial and spiritual end-of-life needs were consistently underestimated by physicians (Table 
2). These differences persisted after multivariate analyses were performed to control for sex, race, 
socioeconomic status, household, composition, religion, and religiosity.  
 
 
Table 2: Quality of life attributes ranked by order of importance by patients and physicians at 
the end of life (Steinhauser et al, 2000) 
 
 Participants agreeing the importance of the attribute 
Attributes Patients Physicians 
Being mentally aware 92% 65% 
Being at peace with God 89% 65% 
Not being a burden to family members 89% 58% 
Being able to help others 88% 44% 
Being able to pray 85% 55% 
Able to plan own funeral 82% 58% 
Not being a burden to society 81% 44% 
Feeling one’s life to be complete 80% 68% 
P = .001 for all comparisons 
 
Notwithstanding these differences, more than half of the survey items showed consensus 
between all 4 groups including pain and symptom management and the importance of preparing 
for the end-of-life. These echo the results of another study that many renal patients wanted to 
plan ahead for their death when this became inevitable (Christakis and Iwashyna, 1998), a process 
which requires clear communication in order to facilitate shared decision and the primacy of 
patients’ wishes at this time.  
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The views of care home managers were elicited by one postal survey of 261 suitable care homes1 
selected from a list of registered institutions in one English county by Froggatt and Payne (2006). 
Responses were received from 115 (46%) of the homes sampled, of which only 81 (33%) were 
suitable for analysis. Responses indicated that there is a marked lack of clarity as regards end-of-
life care, one manager describing it as ‘a continuation of existing care’ (p344) whilst others related 
it to the care provided to residents in the ‘last days’ or the ‘final stages’ of life whilst another 
added somewhat quizzically that it is provided when ‘the end is near’ (p344). Unlike many 
settings, post-mortem care featured highly in their definitions of end-of-life care, one manager 
regarding it simply as verifying that death had occurred whilst another defined it as the 
performance of last offices. A third manager suggested that it simply consisted of checking the 
pulse and phoning the GP to certify the death whilst another included the dignified departure of 
the deceased to the care of a funeral director as being included within this remit.  
 
Interestingly, only one manager spoke about end-of-life care in relation to the provision of 
palliative care for dying residents, and most related it to the events leading up to and immediately 
following the death event. This is interesting given that the majority (505 or 70%) of deaths 
reported in the study occurred within the care home, only 214 (29%) taking place in hospital and 8 
(1%) in hospice settings. Moreover; 85% (564 deaths) were from causes other than cancer, a 
situation in stark contrast to the majority of deaths occurring in specialist palliative care settings 
or acute environments where most end-of-life care research takes place (Eve and Higginson, 
2000). Unlike specialist palliative care settings however, the study indicates that patients dying in 
nursing homes are likely to experience a broader range of illnesses and consequently experience 
many different death trajectories in settings which are not focused on the care of the dying and 
invariably have fewer qualified staff than either hospices or hospitals. This warrants further 
consideration, as does the continuing ambivalence of many older people to discuss end-of-life 
care issues with health care professionals, which is in stark contrast to the aims of the philosophy 
and may not simply be due to people’s fears that attempts will be made to ration their access to 
more intensive interventions as discussed previously (Kane, 2003). 
 
3.4 Death trajectories and ambivalence about end-of-life care discussions 
 
The concept of death trajectories has long been used to illustrate similarities and dissimilarities in 
patient experience as they approach death (Field and Cassel, 1997; McCormick and Conley, 1995; 
Glaser and Strauss, 1965). Those credited with developing the term noting that ‘the dying 
                                            
1 In order to be eligible for the study, care homes had to be registered for the care of adults > 65 years of age by the Commission for Social Care 
Inspection and provide personal or nursing care to those with ‘old age’, ‘dementia’, ‘physical impairment’, ‘mental impairment’, ‘sensory 
impairment’ and/or ‘terminal illness’.   
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trajectory of each patient has at least two outstanding features and variable properties… duration 
and shape’ (Glaser and Strauss, 1965 p6). It is clear that at least three distinctive death trajectories 
are acknowledged within the early literature on this topic. Glaser and Strauss (1968) described 
these as abrupt or surprise deaths, expected deaths (which may be long and lingering or of 
relatively short duration), and entry-re-entry deaths, in which individuals may enjoy a 
comparatively good quality of life between episodic bouts of worsening ill-health or disease.    
 
One much cited paper by Lunney et al (2003) reporting the results of a US cohort analysis on data 
gathered as part of a prospective, longitudinal interview study of 14,456 respondents aged 65 
years or more (Comoni-Huntley et al., 1990) found that ‘frail’ decedents (classified by entry into a 
nursing home for all or part of the period preceding annual interview) were 8 times more likely to 
have functional deficits than those dying suddenly, one and a half times more likely to die than 
those dying with cancer, and three times more likely to die than those with organ failure after 
controlling for age, sex, race, education, marital status and other demographic variables including 
time from final interview to death. Their study supported the findings of others that older frail 
decedents are more likely to experience a sharp decline in functional status2 than age-matched 
survivors (Wolinsky et al., 1996; Lawton et al., 1990) notwithstanding the fact that specific medical 
conditions also influence functional ability in the dying, cancer patients experiencing a sharper 
decline in functional status in the last months than those dying from more chronic illnesses (Teno 
et al., 2001).  
 
As a consequence of this, and earlier analyses conducted by the same authors on data from 
Medicare claimants Lunney et al, (2002) and Lunney et al (2003) proffer four theoretical death 
trajectories which are sudden death, terminal illness (including end-stage cancer), organ failure 
(defined for the purposes of the study as congestive heart failure and chronic lung disease or 
similar) and importantly, given recent demographic changes within most developed countries, 
frailty – a concept which is increasingly considered within the literature when determining the 
point at which end-of-life care should begin. One possible weakness of the study is that whilst 
99% of decedents (n=4,871) participated directly in the interview process at baseline, only 74% 
did so in their last year of life due to cognitive or physical impairment, researchers relying upon 
the proxy reporting of decedents functional status at this time (Kutner et al., 2006; McPherson 
and Addington-Hall, 2003), although 316 of the decedents were interviewed within the last month 
of their life, which is one of the largest ante-mortem data sets encountered in the literature 
reviewed.      
                                            
2 Functional status was assessed using 7 activities of daily living (ADL), namely bathing, walking across a small room, grooming, dressing, eating, 
transferring from bed to chair and using a toilet in addition to other activities such as kneeling, crouching, climbing a flight of stairs, walking half a 
mile and respondents’ ability to do ‘heavy’ housework such as vacuuming and washing a floor. 
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In addition to objective measures of disability using the ADLs listed below, the researchers also 
found that a diagnosis of cancer, heart disease, diabetes, hip fracture or stroke also predisposed 
the individual to death in comparison to age matched survivors (0.76 versus 0.44; P < .001), cancer 
deaths tending to be more common among the youngest age group3 (mean age 78.7 years, SD 
6.9) in comparison to sudden death (80.4 years SD 7.8), organ failure (82.3 years SD 7.7) and 
frailty (85.1 years SD 7.2), with 77% of the latter group being 80 years or older when they died. 
Where overlap existed, it was more likely to include frailty (also identified in 320 or 8% of organ 
failure decedents and 202 or 5% of cancer decedents). Sex differences in the level of disability 
were apparent, women reporting consistently higher levels of functional disability than men, 
although the trajectory of the decline in both men and women, and in each if the age cohorts was 
similar to the projected trajectory for each group, the mean functional ability of each gradually 
diminishing over the last year of life.  
 
When the disability trajectories for each group were analysed, cancer patients were found to have 
a lower level of functional disability than those in the organ failure or frail groups in the early 
months of their final year of life, but experienced a marked decline in their functional ability in the 
last three months of life. This is consistent with expected disease trajectories and patterns of 
death in malignancy, particularly where metastases are present. The functional ability of 
decedents in each of the non-sudden death groups were markedly worse in the last three months 
of life however, indicating that a sudden decline in functional ability may be an appropriate 
prognostic indicator in determining when death is likely to occur and when end-of-life care should 
commence. However, whilst the researchers were able to confirm their hypothesis that death 
trajectories demonstrated predictable differences in the onset, severity and prognostic value of 
functional disability in each of their groups, there was a more marked variation in individual 
differences within these groups, and some overlap between frailty as a variable. Those dying with 
frailty, cancer, or from organ failure made up 20%, 21% and 20% of the sample respectively, 24% 
of the deaths being attributed to causes other than these or sudden death, which made up 15% of 
the sample.  
 
The existence of so large a group (n=990) dying without malignancy, organ failure or apparent 
frailty in the months leading up to their non-sudden deaths is interesting in so far as this group 
had a higher incidence of co-morbidities (n=1.45 SD 0.66) in comparison to all other groups (mean 
1.05 for cancer, 1.04 for organ failure and 1.08 for frail decedents), and a baseline of zero in the 
referent (sudden death) group who were more likely to be males between the ages of 65 and 74 
years who had the lowest rates of ante-mortem disability calculated by functional status. The 
                                            
3 The age groups were 65-74 years, 75-84 years and 85 years or more. 
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researchers conclude however, that ‘only short-term expected deaths such as may occur with 
cancer decedents, are likely to have a predictable terminal period that meets the public 
expectation of dying, and the health care requirements for hospice [or end-of-life] care’ (p2390-
2391). The vast majority of people do not die from expected deaths however, but from ‘acute 
complications of an otherwise chronic condition, most likely without a discrete terminal illness 
phase’ (p2391) which may preclude their being assessed for hospice or specialist palliative care 
provision, or even having a comprehensive assessment of their end-of-life care needs made. 
Frogatt and Payne (2006) reiterate this point when arguing that fewer than 10% of those dying in 
care homes do so with a recognisable terminal illness, more than 50% dying after a prolonged 
period of general deterioration (Seymour et al., 2005; Davies and Higginson, 2004). The 
knowledge and skills needed to care for care home residents at the end-of-life are very different 
therefore, from those required to care for patients in acute or specialist palliative care settings, 
but older people’s understanding and views about end-of-life care are only now beginning to be 
investigated by researchers (Seymour et al., 2005) whilst still less is known about the perspectives 
of family members in respect of such issues.   
 
Studies since the phrase ‘death trajectory’ was first coined clearly demonstrate that many of those 
entering the final stages of their lives (and those who care for them) have some forewarning 
about their impending death and may manifest signs of physical, functional, psychological and/or 
social deterioration which are gradual and predictable. Others, perhaps the majority, are less 
likely to exhibit such a clear or predictable decline however, and may live for many months in 
what Field and Cassel (1997) called a ‘Living-Dying Interval’,  McCormick and Conley (1995) 
describe as the ‘Chronic Living-Dying Period’ and van Gennep (1965) describes as the ‘Liminal 
Phase’ of life. This period may be considerably longer than that traditionally associated with end-
of-life care, particularly where some measure of treatment is available for the underlying 
condition such as cardiac, pulmonary and renal disease. Others, such as those with life-long 
conditions such as cystic fibrosis, neurodegenerative disorders or sickle cell disease may face the 
prospect of a relatively sudden (though predictable) death at an unknown point during their lives. 
It is difficult to know when EOLC should begin in such circumstances, since any attempt at 
prognostication is fraught with difficulty and likely to be inaccurate in such cases. Many attempts 
have been made to use statistical probability when determining survivorship over a specified time 
period such as six or twelve months (Lynn et al., 1997), but the propensity for patients to die from 
sudden or otherwise unanticipated conditions such as treatment failure (in cancer for instance) or 
a superimposed infection may hasten death considerably. 
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Medical technology may also obfuscate the living-dying trajectory for many (Field and Cassel, 
1997), and there is considerable debate within the literature about the efficacy or futility of 
measures such as the use of dialysis, mechanical ventilation, antibiotics, parenteral feeding, 
intravenous fluids or cardiac resuscitation during the final phase of a patient’s life. We have 
moved a long way indeed since Montaigne (1575) commented that to die of old age is a privilege 
rarely to be seen. The majority of those dying in any one year will be elderly (Field and Cassel, 
1997). These individuals are more likely to live alone, with an elderly or infirm carer, or in a 
residential home than any other group, whilst increasing geographical mobility may accentuate 
the problem of loneliness or isolation felt in relation to other members of their family. During this 
time, patients may be fully aware that they have a progressive disease which is likely to kill them, 
but may not regard themselves as actively dying. In this respect, they demonstrate behaviours 
similar to those described by Patterson (2003; 2001) in her ‘shifting perspectives’ model of chronic 
illness which will now be discussed.  
 
Derived from a meta-analysis of 292 qualitative research studies on patient experiences of chronic 
illness, the model rejects the linearity of traditional chronic illness (or even living-dying) 
trajectories espoused by those such as Corbin and Strauss (1992), and posits one based upon two 
dialectic relationships, one between illness and wellness, and another between the internal self 
and the external world. Individual perspectives, health beliefs, coping mechanisms and cognitive 
appraisal of the threat posed to them by their worsening condition all play a part in the 
individual’s perception of themselves as a chronically sick (and potentially dying) individual as well 
as one who is still living through the last phase of their life. Thus the patient’s perceptions of their 
own lived reality, rather than those of the clinician are the most important factors in determining 
how they interpret, report and respond to changes in their condition as they enter the end-of-life. 
Patients may experience periods where their illness (and possible death) is in the foreground of 
their consciousness, during which time both theirs, and their carer’s attention is focused towards 
the life-limiting burden of the illness and any suffering, losses or treatment related to it. This is 
likely to be balanced by periods of comparative wellness, in which the patient’s internal and social 
self, rather than the increasingly incapacitated body becomes the source of the patient’s identity, 
and some may move from being victims of circumstance to managers of their situation with a 
renewed appreciation for life and others as they enter its final phase.  
 
In either case, carers need to assist the patient in finding meaning in their illness (Cumbie et al., 
2004) conscious that both its meaning and  severity are constantly subject to re-evaluation 
(Stuifbergen et al., 1990). Whether one agrees with the shifting perspectives model or not, the 
need for patients to balance their need for support against the quest for normality or ordinariness 
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is well documented (Kralik, 2002). This is clearly demonstrated by Gott et al. (2008) whose in-
depth interviews with 40 elderly end-stage cardiac patients (median age 77) showed that older 
people’s views often conflicted with the values upon which most palliative or end-of-life care is 
predicated, many respondents saying that whilst they would like the opportunity to put their 
affairs in order, they did not want to discuss the imminence of their death, assuming that this was 
as much a consequence of their advanced years as their underlying condition. Citing earlier work 
by Seymour et al. (2005; 2004) about the reservations or ambivalence older people sometimes 
show when asked to consider their own deaths, Gott et al. observe that, ‘such ambivalence was 
apparent in the attitudes of the participants in our study who, whilst in the main acknowledging 
their likely limited prognosis, did not want to dwell upon this [since] they felt so doing destroyed 
the hope they needed to enjoy their day-to-day lives’ (p1119). 
 
This ambivalence has also been demonstrated in relation to the formulation of advance directives 
(Seymour et al., 2004) and communication about end-of-life care in general (Hoffman et al., 1997) 
in this client group, both of which have been much advocated in an attempt to improve end-of-life 
care planning (Murray et al., 2007; Winter and Parker, 2007; Becker et al., 2007; Davison and 
Torgunrud, 2007). Seymour and her colleague’s UK study demonstrates that advance directives 
are primarily understood in terms of their capability to increase personal autonomy and assist the 
family of the deceased in the period immediately surrounding the death, but concerns about the 
inappropriate use of such directives and the possibility that the patient’s preferences may change 
over time have led to their being largely discounted in this client group (Seymour et al., 2004).  
The research showed that in contrast to current guidelines on their use (General Medical Council, 
2001; British Medical Association, 1995), elderly patients saw them primarily as a non-binding 
guide to relatives at a difficult time of transition, and not as a bilateral arrangement between the 
patient and their physician which ought not to be vetoed by family members.  
 
Furthermore, little consideration was given to their capacity to safeguard the moral autonomy of 
patients, a finding supported by that of Gott et al (2008), which suggested that older patients have 
a much narrower concern for autonomy than bioethicists, published guidelines, or those 
advocating their use as an aid to end-of-life care planning would like. Seymour and her colleagues 
point instead, to the profound sense of mutual interdependency which arises between a person 
coming to the end of their life and those in their immediate family circle, a complex 
biopsychosocial dynamic which may often be underestimated by professional carers, as has 
already been suggested in relation to the concerns of end-stage renal patients which are often 
underestimated by health care professionals (Steinhauser et al., 2001; 2000). These indicate that a 
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change in the goals of care is needed if patients are to die a dignified and socially integrated death 
irrespective of the setting in which they die (Hov et al., 2007; Kaufman, 2000; Fins et al., 1999). 
 
4.0 Triggers to end-of-life assessment   
 
Various attempts have been made to develop prognostic or diagnostic tools which will reliably 
indicate that death is now probable. Measures which rely upon probability, and in particular, upon 
demographic or non-clinical variables are less likely to provide reliable data than those related to 
the patient’s physical condition – albeit in many cases, no less accurate. Attempts have been 
made however to develop such tools using actuarial, demographic or health indices to predict the 
probability of death occurring for specific groups of patients in any given period. These shall now 
be considered, providing as they do, instruments of varying reliability, sensitivity and specificity 
for such a purpose. They are posited as exemplars of some of the exciting work currently taking 
place to improve end-of-life prognostication and not as an exhaustive analysis of every available 
tool as the size and scope of this review preclude such an analysis. 
 
4.1  The problem with prognostication when death is ‘imminent’ 
 
In order to provide appropriate end-of-life care in the last days or hours of life it is first necessary 
to identify that the patient is actively dying since quality end-of-life care is unlikely to be achieved 
if an accurate diagnosis that death is imminent cannot be made (Leland, 2000). Accurate 
prognostication is notoriously difficult however, and there is some dispute as to the optimum time 
at which this is both clinically feasible and socially acceptable given the impact of such news on 
the individual concerned and the members of his or her family. The need to distinguish between 
the likely imminence of death (whether stated in days, weeks or months), and the mere possibility 
that death may occur at some unforeseen point in the future has been the subject of considerable 
debate for many years. However, if one envisages that communication of the patient’s transition 
from active or curative treatment to end-of-life care is necessary in order to elicit necessary 
changes in the patient’s management plan and the withholding of interventions considered futile, 
it is incumbent upon health professionals to do this accurately as well as sensitively, whether in 
the days leading up to an imminent death, or at the time when a patient’s gradual decline is 
predicted some months in advance of their death (as may happen in cancer or to a lesser extent, 
end-stage cardiac or pulmonary disease). 
 
The literature search identified relatively few papers which investigated nurses’ ability to 
recognise dying in the last days or hours of life, including Parker-Oliver et al. (2004) and Porock 
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and Parker-Oliver (2007). In the latter study, the researchers interviewed 14 staff from both urban 
and rural long-term care settings and found that nurse recognition that the resident was entering 
the terminal phase of life was initiated by a mixture of ‘ambiguous clues’, ‘decision clues’, ‘ready 
to go clues’, ‘withdrawal clues’, and ‘visible clues’. Ambiguous clues included falls, diminishing 
appetite or infections which may indicate deterioration in the patient’s condition, but might also 
be preventable or reversible. Ambiguous clues also included psychosocial events such as the 
passing of a significant event (such as a birthday or the birth of a grandchild which the resident 
had been particularly looking forward to) and the sense that these marked the beginning of life 
closure in some way. Decision clues included the residents questioning the efficacy of long-term 
medications or other health interventions and expressing a preference for these to stop. 
Respondents in the study noted that this decision often precipitated a calm acceptance on the 
part of the resident and a sense of relief that they had exerted their autonomy – perhaps after 
many years of unquestioningly accepting the advice of their physician or the indignities of medical 
interventions now thought futile.  
 
Ready to go clues included residents asking about legal assistance for writing a will or considering 
the arrangements for their funeral, but might also include conversations about the completeness 
or finality of a resident’s life, or their lack of fear about the ‘inevitable’ and what may lay ahead. 
Withdrawal clues included small ‘leave-taking’ comments or the expression of thanks for services 
rendered, followed by psychosocial withdrawal. This stage may be accompanied by requests not 
to join others at meal times or to participate in group activities. Even normal conversation may be 
muted or stifled. Visible clues leave no question that the patient is now actively dying and include 
pallor, cyanosis, oedema or mottling of the skin. Most respondents admitted that they seldom 
thought about end-of-life or palliative care interventions until this latter phase because of the 
apparent lack of urgency in earlier stages of the dying process which may precede death by many 
days or a matter of weeks. The authors noted however, that referral to hospice was not 
considered appropriate at this time.  
 
The authors of a separate paper on ‘turning points’ in end of life prognostication (Jakobsen et al., 
2006) argue that clinical identification of dying is irretrievably linked to a reorientation in the goals 
of care provided to patients who are dying, but found that few studies examined when – or 
indeed whether such a decision was actually taken by clinicians in practice. These authors 
therefore examined the health care records of 229 people who had died at home or in hospital in 
Sweden during 2001. Analysis of the medical records showed that there were several significant 
turning points in clinician’s evaluations of patient mortality risk which led to a deliberate change in 
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the patient’s plan of care. These included phrases such as, ‘no longer feasible to treat’, ‘the 
patient is beyond active therapy’, ‘continue with best possible palliative care’, ‘for withdrawal of 
life prolonging therapies’ and ‘decreasing blood pressure despite IV hydration. No CPR, palliative 
care only’. Such turning points were found in 160 patient records and in most cases, a deliberate 
change in the goals of care was subsequently prescribed. The mean time interval between 
recorded turning points and the death of the patient was 19 days (median 5 days). For individuals 
without cancer the interval was almost 11 days (median 3 days). Thus the time interval between 
the turning point and death differed significantly between patients with cancer and other 
conditions, supporting the notion that cancer patients have significantly longer to prepare for 
death than other patient groups, and confirming the impression that cancer tends to follow a 
predictable death trajectory in comparison to other illnesses. This is consistent with other studies 
which show that there remains a great deal of uncertainty in identifying which acute 
exacerbations of a non-malignant illness are likely to be the last as the death trajectories for such 
conditions can be so variable (Nolan and Mock, 2004; Lunney et al., 2002). 
 
Elliott et al (2007) point out that the majority of methods used to calculate a patient’s prognosis 
are based on biological, physiological or functional indicators which are primarily by the physicians 
themselves. Many of these tools, such as the Karnofsky Performance Status scale are one-
dimensional, observer-rated scales that have modest predictive value although used extensively in 
the studies cited in this review. In contrast, health-related quality of life (HRQOL) instruments 
based on patient’s own perceptions of their health status tend to have stronger theoretical 
underpinnings than disease status or subjective medical judgements (Cella, 1995), but most were 
not designed specifically for the assessment of end-of-life patients. In their study, Elliott and his 
colleagues attempted to determine the utility of the Missoula-Vitas Quality of Life Index (MVQOLI) 
in end-of-life (hospice) patients in order to determine whether the MVQOLI accurately measures 
HRQOL and could be used to predict patient survival times.  
 
The MVQOLI contains 16 items in five domains including the perceived level of physical symptom 
distress, function, interpersonal relationships, personal well-being and transcendence/spirituality. 
Patients are asked to rate their satisfaction in each domain on a 5-point scale ranging from agree 
strongly to disagree strongly. In addition, patients’ global quality of life is ranked on a single item 
5-point scale ranging from worst possible to best possible. Cancer was the most common terminal 
diagnosis (59.6%) in the sample of 1,047 patients admitted to the hospice although the most 
common cause of comorbidity was end-stage cardiac disease. The median survival time from 
admission to hospice and the patient’s eventual death was 17 days (range 0 to 925 days). 
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Unfortunately, however, the MVQOLI demonstrated no prognostic utility in their study and 
performed worse than the observer rated Karnofsky Performance Status scale and the modified 
activity of daily living score (MADLS) which performed better in showing associations with survival 
time. Meanwhile, more research is needed into psychosocial factors which might indicate that 
death can be expected soon (Appendix 1). 
 
4.2   Studies predicting mortality in the longer term 
 
In their rationale for the development of the INTERMED palliative care assessment tool, 
Mazzocato et al. (2000) argue that documentation of patient need is still often restricted to the 
assessment of physical and psychological symptoms or quality of life, even in palliative care 
settings. Whilst some exceptions exist, such as the Support Team Assessment Schedule (STAS) 
(Higginson and McCarthy, 1993; Higginson et al., 1992), which evaluates current physical and 
psychological symptoms, expressed care needs, financial concerns, communication among health 
care professionals and family members; most still do not address broader issues of relevance to 
those in the final stages of their disease process such as psychological adjustment and social or 
spiritual concerns, in spite of evidence provided by Vernooij-Dassen et al. (2007) that explicit 
clarification of patient concerns frequently identified new areas of need in the psychosocial and 
spiritual domains of care.  
 
INTERMED was developed therefore, to assess and document information concerning these needs 
in an integrated manner, and to see whether the needs of specific subgroups requiring intensive 
palliative care involvement could be identified in order to tailor the delivery of these services 
appropriately. The other aim of the project was to ensure that clinical decision making with regard 
to the type, setting, duration and appropriateness of treatment was better managed. The tool 
specifically addresses patient prognosis, social vulnerability and perceived threat to life in patients 
accessing palliative care services, and whilst not tailored specifically towards end-of-life care, the 
authors point out that the tool is more stable over time than the STAS model and importantly, 
complements decision making processes in periods of transition whilst taking account of 
diagnostic and prognostic complexity, residential instability and problems accessing appropriate 
health care services which may be crucial when developing an appropriate management plan for 
those entering the final stage of life.  
 
In their cluster analysis of the INTERMED scores on different patient groups, the authors found 
that the tool provided a reliable way of accurately assessing the palliative care needs of patients 
demonstrating higher levels of psychological and social comorbidity who might benefit from a 
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comprehensive psychosocial as well as physical assessment, and consideration of their complex 
discharge needs when returning home from the acute care setting. The study did have some 
weaknesses however as the authors only included patients with a cancer diagnosis (n=82) and 
deliberately excluded those with nonmalignant disease. Notwithstanding these issues, the tool 
has been positively evaluated in the Netherlands, where it has been used to consider the care 
needs of those with complex co-morbidities (Latour et al., 2007), and tested in relation to its 
reliability and stability when assessing the complex biopsychosocial care needs of patients with 
multiple sclerosis (de Jonge et al., 2004). These same authors have also used the tool to assess 
quality of life and predict one-year survival in end-stage renal patients (de Jonge et al, 2003) and 
found that age (>65 years), co-morbid diabetes and the INTERMED score were the three variables 
most likely to identify those patients with a poor quality of life and significantly (from an end-of-
life perspective), patient mortality in the early stage of treatment. The report’s authors suggest 
therefore, that the tool provides a useful reminder to health care professionals to initiate end-of-
life discussions about patient’s future care preferences, fears and concerns at an earlier point on 
the disease trajectory, and to refer patients with end-of-life care needs to the appropriate services 
in a timely manner. It should be noted however, that these and other papers evaluating the tool’s 
effectiveness tend to come from the same stable of researchers responsible for developing and 
disseminating the tool (the Stichting INTERMED Foundation), including some involved in the study 
by Mazzocato et al. (2000).  
 
Admission to long-stay care signals the beginning of end-of-life care for many older people. It is 
not always possible however, to predict with any certainty the trajectory that may lead to their 
ultimate death, or whether their remaining life span will be short or long. One well-conceived 
study making use of data from the Minimum Data Set (MDS) designed by Morris et al. (1990), a 
comprehensive and well evaluated assessment instrument (Phillips et al., 1996; Hawes et al., 
1995; Hawes et al., 1992) of more than 400 items compulsorily applied to all nursing home 
residents in the United States for Medicare and Medicaid funding purposes was conducted by 
Porock et al. for the calendar year 1999 (Porock et al., 2005; Porock et al., 2003). The complete 
instrument is completed for each nursing home resident within 14 days of admission, and an 
abbreviated form administered at 90 day intervals, on each anniversary of the admission, and 
again when a significant change in the resident’s health status occurs. The researchers selected 
the 50 MDS items most likely to accurately predict death within a six-month period on the basis of 
previously published research findings and analysed data on these from the MDS scores of 43,510 
nursing home residents in the state of Missouri against death registrations of nursing home 
residents in the state over the same twelve-month period.  
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The 50 variables considered most likely to predict death from the MDS fell into four main 
categories: demographics such as age and sex, clinical pathology such as a diagnosis of cancer, 
chronic obstructive pulmonary disease, congestive cardiac failure, clinical signs and symptoms 
such as shortness of breath, weight loss, cognitive impairment, pain and deficits in residents’ 
activities of daily living; and adverse events such as falls, infections, hospitalisation or the loss or a 
spouse or partner. Data from the 43,510 residents were randomly divided into 20 subsamples in 
order to avoid overestimating the clinical significance of small but statistically significant 
differences in this huge sample, and to avoid known problems associated with using a step-wise 
selection of predictor variables. This ensured that only those variables identified as significant 
(p=0.01) in every subsample were included in the prognostic algorithm subsequently developed. A 
significance level of 0.01 rather than 0.05 was used to offset the relatively large power of the still 
large subsamples, and to ensure that only clinically significant variables were identified by the 
analysis of the data. Twenty-six of the 50 variables were subsequently found to have a significant 
relationship with 6-month mortality (as calculated from the death certificates), but these were 
then subjected to a step-wise logistic regression analysis to see which of them remained after this 
procedure. Each variable received a ranked score dependent upon how often it was selected by 
the stepwise procedure and the step at which it was selected. Total scores and the frequency with 
which each variable appeared in the 20 subsamples were used to determine the predictive 
reliability of each variable (see Table 3 below).  
 
Table 3: Frequency and Scores for Variable Entry into the Algorithm Development Data Set 
Ranking Variable Name Frequency of model entry 
Total score of 
ordered entry 
1 Requiring assistance with ADLs (0-7) 20 379 
2 Shortness of breath 20 338 
3 Cancer diagnosis 20 328 
4 Recent admission to nursing home 20 322 
5 Poor appetite 20 287 
6 Male sex 20 277 
7 Deteriorating condition  20 274 
8 Weight loss 20 249 
9 Chronic heart failure 20 236 
10 Age 20 190 
11 Renal failure 20 180 
12 Cognitive performance scale score <6 19 119 
13 Alzheimer’s disease or dementia 18 97 
14 Dehydrated 17 129 
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It became clear that 14 variables were far more reliable indicators of six-month mortality, of 
which two, cancer and age, and recent admission and deterioration were consistently related to 
each other. The interaction between admission to the nursing home and deterioration suggested 
that these two variables were not simply additive (or causal) in nature whilst interestingly; the risk 
of dying of cancer in a six-month period was greater the younger the nursing home resident, thus 
the points allocated for this mortality risk actually decrease the older the resident is (Appendix 2). 
 
The 14 most frequently occurring variables together with the two interactive variables (cancer and 
age, and recent admission and deterioration) were then selected for the development of a 6-
month predictive MDS Mortality Risk Index (MMRI) which was used to 
estimate the 6-month mortality of Missouri nursing home residents in the original sample against 
national data from the 1997 National Health Survey (Gabrel and Jones, 2000). Kaplan-Meier 
survival curves illustrated a close resemblance to the 6-month probability of dying when 
calculated using the MMRI and compared back to the death certificate data. In practice however, 
the tool was too complex to be completed in the clinical setting although a simplified version of 
both the tool and the scoring sheet has now almost been completed and will be published shortly 
(personal communication D. Porock 25th October 2008). 
 
5.0 Conclusions and recommendations 
 
In their end-of-life care strategy, the National Council for Palliative Care (2006) suggest that it may 
be ‘useful to regard end-of-life care as simply an everyday expression that may be easily 
understood by the general public’, and eschew ‘importing’ definitions from abroad as ‘these do 
not necessarily fit well with current supportive and palliative care policy and health care system in 
this country’ (p2). There are several problems with this statement however. In the first instance, 
this review of the literature clearly demonstrates that the nature, scope and duration of end-of-
life care, together with the factors which trigger its initiation are far from understood, and still less 
agreed by health care professionals, whilst the ‘general public’ are scarcely aware that it exists as 
a separate entity from the broader remit of palliative (and to a lesser extent, supportive) care 
provision. There can be little doubt however, that improvements in end-of-life care services 
provided to dying patients and their families need to be greatly improved; but these need to be 
conceptualised and developed with the greatest possible consensus if cracks are not to appear in 
the edifice that is currently being constructed. Greater clarity is certainly needed if both the 
general public and health care professionals are to share a common coin of communication when 
discussing and negotiating care outcomes at life’s end, and this consensus needs to begin with 
those offering these services. 
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In seeking this clarity, it is crucial that both home-grown and imported definitions of end-of- life 
care are subjected to careful scrutiny, and a full analysis of the concept undertaken in order to 
determine the scope of practice of all those engaged in the delivery of such services. Furthermore, 
international consensus is needed on this subject if international comparisons of care provision 
and effectiveness are to be made, and both policy makers and health care professionals held to 
account for the decisions they make in allocating finite resources to those with complex and often 
ongoing needs. Imported definitions on end-of-life care are no less useful than those on health or 
palliative care, both of which were developed as a result of international consensus and were 
subsequently adopted in the UK. If this is not done, it will be difficult for researchers to develop 
prognostic tools which have external validity outside their own borders as each will be working to 
different definitions of what end-of-life care is or ought to be. 
 
Of somewhat more fundamental importance however, is the question ‘should the care of dying 
people in the twenty-second century be driven by the ‘current supportive and palliative care 
policy and health care system in this country’ as the authors of the submission suggest, or should 
it, like the goals of care established with individual patients, derive from a thorough and 
comprehensive assessment of need. It would appear from this very brief review of the literature 
that very little consideration has been given to listening to the views of those in need or receipt of 
such services although Macmillan’s Cancer Voices initiative may provide one such example for this 
exercise. Form it is said, should follow function, and any temptation to mould end-of-life care 
services around current systems is likely to result in fragility given that systems and services are 
subject to constant redefinition and reform. Conversely, it is clear from the literature that 
patients’ end-of-life concerns remain the same across different client groups, racial, social and 
ethnic divides, as well as international borders and historical epochs. This is hardly surprising given 
that one is dealing with the most basic of human concerns when considering end-of-life care, 
including man’s frailty, vulnerability, anxiety and quest for dignity in the face of his own mortality. 
A better understanding of these concerns will provide a surer foundation for the establishment of 
a service than the ‘current supportive and palliative care policy and health care system in this 
country’ currently allows, and prevent some of the unfounded assumptions made by health care 
professionals about dying peoples’ genuine concerns, fears and needs as they approach death. 
 
These concerns are not best served by attempts to appropriate particular disciplinary territories or 
boundaries, and it is encouraging that the literature acknowledges the necessary interplay 
between palliative, supportive and end-of-life care. On the whole, the literature does not appear 
to have addressed the question of whether these are in fact the same thing however, and we 
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must be careful of tailoring a new set of clothes which leave our conceptual and professional 
nudity clearly open to the gaze of the general public, our patients and their carers. They clearly 
see few of the demarcations which are currently being created by policy makers and service 
providers within this area of care, and their concerns revolve much less around semantics than 
equality of access, dignity, sensitivity, and the availability of appropriate resources to assist them 
in their time of greatest need. To this end, it is important that renewed attempts are made to 
prognosticate accurately, treat effectively and care appropriately as and when the need arises. 
The need for further research into the area of end-of-life care is clearly apparent, and should 
exercise the minds of clinicians, service commissioners and academics alike. Large scale, 
international studies should be set up to establish the parameters of such valuable research and 
to arrive at consensus in respect of the terminology used, as well as developing comprehensive 
databases on morbidity and mortality such as that designed by Morris et al. (1990) in the United 
States. These will provide vital data for researchers and clinicians alike, and should address 
current gaps in our knowledge base on this most vital of subjects. 
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Appendix 1: Psychosocial indicators that death may be expected  
 
 
 
• social withdrawal and disinterest 
• increased contemplation and revisiting memories 
• expressions of regret or sadness 
• evaluating life and achievements 
• reassuring others that death is not feared or death anxiety 
• engaging in the ‘five tasks of the dying’ 
o asking forgiveness 
o offering forgiveness 
o offering thanks and gratitude 
o offering sentiments of love 
o saying goodbye 
o letting go 
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Appendix 2: 6-month MDS Mortality Risk Index (after Porock et al, 2005) 
 
 
 
6-month MDS Mortality Risk Index  
   
 Age without cancer     
      
 ≤ 69 yrs  1 point     
 70-78 yrs  2 points     
 79-88 yrs  3 points     
 89-98 yrs  4 points     
 ≥ 99 yrs  5 points Age score (non cancer)   
      
or 
 
 Age with cancer     
       
 ≤ 74 yrs  8 points    
 75-84 yrs  7 points    
 85-94 yrs  6 points    
 ≥ 95 yrs  5 points Age score (with cancer)   
      
 CPS score     
      
 0-1  0 points     
 2-4  1 point     
 5-6  2 points  CPS Score   
      
+ 
 
 Admission and/or deteriorating score   
    
 Admission only 3 points    
 Deteriorating 3 points    
 Admitted & deteriorating  4 points Admission score      
    +  
 Activity of daily living score* ADL Score (maximum 7)   
      +  
 Shortness of breath  3 points Breathlessness score   
      +  
 Poor appetite 2 points Appetite score   
      +  
 Male  2 points Gender score   
      +  
 Weight loss  Weight score   
      +  
 Chronic heart failure 2 points CHF score   
      +  
 Renal failure 2 points Renal score   
      +  
 Dehydrated 2 points Dehydration score   
        
   Sub-Total   
        
 Alzheimer’s disease subtract 1 point Alzheimer’s score -  
        
     TOTAL   
 * add 0-5 points for deficits in each of the following ADLs: bed mobility, inability to transfer between 
surfaces, dressing, ambulation, eating, personal hygiene, elimination depending upon severity. 
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